Key Statistics
Market Cap$32.17M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.86
52W High$8.67
52W Low$1.09
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees—
Price Performance
1 Week+8.04%
3 Month-18.79%
1 Year-84.43%
FinancialsAnnual · QuiverQuant
Revenue$155,000
Assets$57.00M
Liabilities$18.86M
Net Income$30.01M loss
About
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease, and nonalcoholic steatohepatitis. The company is headquartered in La Jolla, California.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze INMB with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.